Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-02-22 1:54:23 pm | Inventiva: Biotech To Consider Despite Short NASH Study Enrollment Pause | SeekingAlpha |
| 2024-02-15 1:35:0 pm | Inventiva reports preliminary 2023 fiscal year financial Information¹ and provides an update on its clinical trial NATiV3 | GlobeNewswire |
| 2024-01-24 1:15:0 pm | Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux | GlobeNewswire |
| 2024-01-10 1:0:0 pm | Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank | GlobeNewswire |
| 2023-12-20 1:0:0 pm | Inventiva announces the randomization of the first patient in China in the NATiV3 clinical trial and provides an update on its clinical development program | GlobeNewswire |
| 2023-12-04 1:5:0 pm | Inventiva announces the positive recommendation of the third DMC of the Phase III clinical trial with lanifibranor in patients with NASH | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information